The invasive T1 bladder tumor: Contemporary issues and rationale for radical cystectomy

Current Urology Reports

Volumn 9, Issue 3, 2008, Pages 179-181

  Stein, John P ^a   Penson, David F ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BLADDER TUMOR; CANCER RISK; CANCER STAGING; CYSTECTOMY; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; NOTE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RISK FACTOR; TUMOR GROWTH; TUMOR RECURRENCE;

CYSTECTOMY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 44449109987     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0031-2     Document Type: Note

References (22)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, CA Cancer J. Clin 2006, 56:106-130.
2. Herr HW: Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J Urol 1991, 145:40-42.
3. Pham HT, Soloway MS: High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder. Sem Urol Oncol 1997, 15:147-153.
4. Peyromaure M, Guerin F, Amsellem-Ouazana D, et al.: Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. J Urol 2003, 169:2110-2112.
5. Shahin O, Thalmann GN, Rentsch C, et al.: A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 2003, 169:96-100.
6. Herr HW: Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin N Am 2005, 32:157-164.
7. Lamm, DL, Blumenstein BA, Crissman JD, et al.: Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder; a randomized Southwest Oncology Group Study. J Urol 2000, 158:62-67.
8. Stein JP: Indications for early cystectomy. Urology 2003, 62:591-593.
9. Cookson MS, Herr HW, Zhang ZF, et al.: The treated natural history of high risk superficial bladder cancer: 15 year outcome. J Urol 1997, 158:62-67.
10. Lambert EH, Pierorazio PM, Olsson CA, et al.: The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int 2007, 100:33-36.
11. Solsona E, Iborra I, Rubio J, et al.: The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. BJU Int 2004, 94:1258-1262.
12. Huguet J, Crego M, Sabate S, et al.: Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 2005, 48:53-59.
13. Stein JP, Lieskovsky G, Cote R, et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001, 19:666-675.
14. Soloway MS, Lopez AE, Patel J, Lu Y: Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994, 73:1926-1931.
15. Wisner C, Pfitzenmaier J, Faldum A, et al.: Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 2005, 95:301-305.
16. Bianco FJ Jr, Justa D, Grignon DJ, et al.: Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004, 22:290-294.
17. Orsola A, Trias I, Raventos CX, et al.: Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005, 48:231-238.
18. Holmang S, Hedelin H, Anderstrom C, et al.: The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997, 157:800-803.
19. Smits G, Schaafsma E, Kiemeney L, et al.: Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998, 52:1009-1013.
20. Herr HW, Donat SM, Dalbagni G: Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007, 177:75-79.
21. Stockle M, Alken P, Englemann U, et al.: Radical cystectomy - often too late? Eur Urol 1987, 13:361-367.
22. Raj G, Herr H, Serio AM, et al.: Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 2007, 177:1283-1286.